{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:17:00Z","timestamp":1779189420388,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1067\/mjd.2000.107945","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:17:08Z","timestamp":1027570628000},"page":"595-604","source":"Crossref","is-referenced-by-count":97,"title":["Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study"],"prefix":"10.1067","volume":"43","author":[{"given":"Alice B.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Shirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Gilleaudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Solodkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Gisoldi d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Mike","family":"Neisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.107945_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archderm.1990.01670320107021","article-title":"HLA region genes and immune activation in the pathogenesis of psoriasis","volume":"126","author":"Gottlieb","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.164.4.1013","article-title":"Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques","volume":"164","author":"Gottlieb","year":"1986","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2000.107945_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1067\/mjd.2000.107945_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.107945_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1987.tb05869.x","article-title":"The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis","volume":"116","author":"Baker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.1988.tb01768.x","article-title":"The pathomechanisms of psoriasis: the skin immune system and cyclosporin","volume":"118","author":"Bos","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib7","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.182.6.2057","article-title":"Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells","volume":"182","author":"Krueger","year":"1995","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2000.107945_bib8","first-page":"1","article-title":"An overview of psoriasis","author":"Weinstein","year":"1993"},{"key":"10.1067\/mjd.2000.107945_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.180.1.283","article-title":"PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy","volume":"180","author":"Vallat","year":"1994","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2000.107945_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bmj.300.6736.1398-c","article-title":"Psoriasis and bone marrow transplantation","volume":"300","author":"Jowitt","year":"1990","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.107945_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(86)91502-3","article-title":"Psoriasis and alpha-interferon","volume":"1","author":"Quesada","year":"1986","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.107945_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0190-9622(07)80010-7","article-title":"Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis","volume":"34","author":"Webster","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1990.01670270083013","article-title":"Psoriasis induced at the injection site of recombinant interferon gamma: results of immuno-histologic investigations","volume":"126","author":"Fierlbeck","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0954-6111(95)90256-2","article-title":"Necrotizing vasculitis and exacerbation of psoriasis after granulocyte colony-stimulating factor for small cell lung carcinoma","volume":"89","author":"Couderc","year":"1995","journal-title":"Respir Med"},{"key":"10.1067\/mjd.2000.107945_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archderm.1988.01670120027005","article-title":"Interleukin 2 and psoriasis","volume":"124","author":"Lee","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107945_bib16","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin lnvest"},{"key":"10.1067\/mjd.2000.107945_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jaut.1997.0175","article-title":"Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4","volume":"11","author":"Bachelez","year":"1998","journal-title":"J Autoimmunity"},{"key":"10.1067\/mjd.2000.107945_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0896-8411(92)90006-C","article-title":"Anti-CD4 monoclonal antibody therapy in severe psoriasis","volume":"5","author":"Morel","year":"1992","journal-title":"J Autoimmunity"},{"key":"10.1067\/mjd.2000.107945_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis oral therapy with a new retinoid","volume":"157","author":"Frederiksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2000.107945_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780370610","article-title":"Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody","volume":"37","author":"Moreland","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2000.107945_bib21","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4049\/jimmunol.135.3.1698","article-title":"Inhibition of humoral immunity in vivo by monoclonal antiobdy to L3T4: studies with soluble antigens in intact mice","volume":"135","author":"Wofsy","year":"1985","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2000.107945_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00007890-199209000-00018","article-title":"Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody","volume":"54","author":"Pearson","year":"1992","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2000.107945_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00007890-199403270-00002","article-title":"CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients","volume":"57","author":"Powelson","year":"1994","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2000.107945_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00007890-199405270-00002","article-title":"Nondepleting anti-CD4 antibodies in transplantation: evidence that modulation is far less effective than prolonged CD4 blockade","volume":"57","author":"Darby","year":"1994","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2000.107945_bib25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/00007890-199705150-00009","article-title":"Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trial in transplantation pilot study","volume":"63","author":"Cooperative Clinical Trials in Transplantation Research Group","year":"1997","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2000.107945_bib26","first-page":"406","article-title":"Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody","volume":"108","author":"Cosimi","year":"1990","journal-title":"Surgery"},{"key":"10.1067\/mjd.2000.107945_bib27","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.136.7.2437","article-title":"Immunotherapy for myasthenia gravis: a murine model","volume":"136","author":"Christadoss","year":"1986","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2000.107945_bib28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.133.4.1938","article-title":"Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells","volume":"133","author":"Brostoff","year":"1984","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2000.107945_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00007890-199009000-00002","article-title":"Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antiobody therapy","volume":"50","author":"Shizuru","year":"1990","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2000.107945_bib30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.8094901","article-title":"?Infectious? transplantation tolerance","volume":"259","author":"Shixin","year":"1993","journal-title":"Science"},{"key":"10.1067\/mjd.2000.107945_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4049\/jimmunol.149.4.1131","article-title":"Altered IFN-gamma and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody","volume":"149","author":"Field","year":"1992","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2000.107945_bib32","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2000.107945_bib33","first-page":"317","article-title":"Psoriasiform dermatitis of AIDS [abstract]","volume":"16","author":"McNutt","year":"1989","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.107945_bib34","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.91.20.9282","article-title":"CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and\/or V beta 13.1 genes","volume":"91","author":"Chang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2000.107945_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0560.1998.tb01694.x","article-title":"Intraepidermal lymphocytes in psoriatic lesions are GMP-17 (TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis","volume":"25","author":"Austin","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2000.107945_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1067\/mjd.2000.107945_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"10.1067\/mjd.2000.107945_bib38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200492649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200492649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:50:58Z","timestamp":1680533458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200492649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0190962200492649"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.107945","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}